The placental barrier is not an absolute barrier; drug transfer depends on drug properties.

• A. The placenta acts as an absolute barrier to all drugs.
• B. The placenta does not limit drug transfer at all.
• C. The placenta is not an absolute barrier; some drugs cross depending on properties.
• D. The placenta always protects fetus from all teratogens.

Answer: (C)

The main idea is that the placental barrier is not an absolute shield; whether a drug reaches the fetus depends on its properties and how they interact with placental transfer processes. Tiny, lipophilic, nonpolar molecules cross easily, especially if they are not ionized. In contrast, large, highly polar or ionized compounds cross poorly. The fraction of drug that is free (not bound to maternal proteins) also matters, because only the unbound portion can diffuse across. Placental transporters can further influence transfer—some drugs are pumped back to the maternal side, reducing fetal exposure, while others may be substrates for uptake into fetal circulation. Because of these nuances, some drugs cross readily while others barely cross, and not all fetal exposure can be avoided.

That understanding makes the statement that the placenta is not an absolute barrier and drug transfer depends on drug properties the best description. The idea that the barrier blocks all drugs, or that it limits transfer not at all, or that it always protects the fetus from all teratogens, misrepresents how placental transfer actually works.